Malcolm Rowland, Ph.D.
Malcolm Rowland is Professor Emeritus and former
Dean, School of Pharmacy, and member and former director (1996-2000), Centre
for Applied Pharmacokinetic Research, University of Manchester, U.K. He is also
Adjunct Professor, Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California San
Francisco (UCSF) and Founder
Member, NDA Partners. He was President, EUFEPS (European Federation for
Pharmaceutical Sciences,1996-2000); VP FIP (International Pharmaceutical
Federation, 2001-2009); Board Member, National Centre for the Replacement,
Refinement and Reduction of Animals in Research (NC3Rs, 2004-2008); and Member,
Governing Board, EU Network of Excellence in Biosimulation (Biosim, 2004-2009).
He received his degree in Pharmacy and PhD, University of London, and was on
faculty, School of Pharmacy, UCSF (1967-75) before taking up a professorship at
His main research interest is physiologically
based pharmacokinetics and its application to drug discovery, development and
use. He is also strongly associated with clearance concepts in
pharmacokinetics. He also participated in the early clinical microdose (CREAM,
EUMAPP) trials, Author of over 300 scientific articles, and co-author, with Dr.
TN Tozer, of the textbooks: Clinical Pharmacokinetics and Pharmacodynamics:
Concepts and Applications, and Essentials
of Pharmacokinetics and Pharmacodynamics. He served as an editor of
Journal of Pharmacokinetics and Pharmacodynamics (1973-2007), and since 1977 has
organised regular residential workshops in pharmacokinetics.